Four days after intravenous injection with methotrexate (60?mg/kg) or saline, rats received saturated ([U-13C]palmitic acid) and unsaturated ([U-13C]linoleic acid) fatty acids dissolved in oil, either as a single bolus by oral gavage or by continuous intraduodenal infusion. We determined plasma and liver label concentrations at specific time points.
We confirmed methotrexate-induced mucositis by villus atrophy using microscopy. Methotrexate treatment severely reduced the appearance of [U-13C]palmitic- and [U-13C]linoleic acid in plasma and liver, compared to controls, either when administered as a bolus or continuously (all at least??63 % , P?<?0.05). Liver [U-13C]palmitic acid appearance was higher than [U-13C]linoleic acid appearance, either when administered as a bolus (2.8-fold, P?<?0.01) or continuously (5.7-fold, P?<?0.01).
The intestinal capacity to absorb long-chain fatty acids is severely reduced in rats with methotrexate-induced mucositis. Continuous administration does not overcome this impairment. The liver takes up and/or retains mainly saturated fatty acids during mucositis.